Multi-drug resistant vibrio cholerae O1 variant El Tor isolated in northern Vietnam between 2007 and 2010

Journal of Medical Microbiology

Volumn 61, Issue 3, 2012, Pages 431-437

  Tran, Huu Dat ^a,b   Alam, Munirul ^c   vu Trung, Nguyen ^a,b   van Kinh, Nguyen ^a,b   Nguyen, Hong Ha ^a   Pham, Van Ca ^a   Ansaruzzaman, Mohammad ^c   Rashed, Shah Manzur ^c   Bhuiyan, Nurul A ^c   Dao, Tuyet Trinh ^a   Endtz, Hubert P ^c,d   Wertheim, Heiman F L ^e,f  

^a National Hospital of Tropical Diseases   (Viet Nam)

^b HANOI MEDICAL UNIVERSITY   (Viet Nam)

^c INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; NALIDIXIC ACID; QUINOLONE DERIVATIVE; SULTAMICILLIN; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BANGLADESH; BIOTYPE; DIARRHEA; GENOTYPE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; VIBRIO CHOLERAE; VIET NAM; ZIMBABWE;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CHOLERA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; VIBRIO CHOLERAE O1; VIETNAM;

EID: 84857090449     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.034744-0     Document Type: Article

References (39)

1. Alam, M., Nusrin, S., Islam, A., Bhuiyan, N. A., Rahim, N., Delgado, G., Morales, R., Mendez, J. L., Navarro, A. (2010). Cholera between 1991 and 1997 in Mexico was associated with infection by classical, El Tor, and El Tor variants of Vibrio cholerae. J Clin Microbiol 48, 3666-3674.
2. Ang, G. Y., Yu, C. Y., Balqis, K., Elina, H. T., Azura, H., Hani, M. H. & Yean, C. Y. (2010). Molecular evidence of cholera outbreak caused by a toxigenic Vibrio cholerae O1 El Tor variant strain in Kelantan, Malaysia. J Clin Microbiol 48, 3963-3969.
3. Ansaruzzaman, M., Bhuiyan, N. A., Nair, B. G., Sack, D. A., Lucas, M., Deen, J. L., Ampuero, J., Chaignat, C. L. & Mozambique Cholera Vaccine Demonstration Project Coordination Group (2004). Cholera in Mozambique, variant of Vibrio cholerae. Emerg Infect Dis 10, 2057-2059.
4. Ansaruzzaman, M., Bhuiyan, N. A., Safa, A., Sultana, M., McUamule, A., Mondlane, C., Wang, X. Y., Deen, J. L., von Seidlein, L. & Clemens, J. (2007). Genetic diversity of El Tor strains of Vibrio cholerae O1 with hybrid traits isolated from Bangladesh and Mozambique. Int J Med Microbiol 297, 443-449.
5. Bhattacharya, T., Chatterjee, S., Maiti, D., Bhadra, R. K., Takeda, Y., Nair, G. B. & Nandy, R. K. (2006). Molecular analysis of the rstR and orfU genes of the CTX prophages integrated in the small chromosomes of environmental Vibrio cholerae non-O1, non-O139 strains. Environ Microbiol 8, 526-634.
6. Choi, S. Y., Lee, J. H., Jeon, Y. S., Lee, H. R., Kim, E. J., Ansaruzzaman, M., Bhuiyan, N. A., Endtz, H. P., Niyogi, S. K. (2010). Multilocus variable-number tandem repeat analysis of Vibrio cholerae O1 El Tor strains harbouring classical toxin B. J Med Microbiol 59, 763-769.
7. CLSI (2010a). Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria. Approved Guideline 2nd edn, document M45-A2 (ISBN 1-56238- 732-4). Wayne, PA: Clinical and Laboratory Standards Institute.
8. CLSI (2010b). Performance Standards for Antimicrobial Susceptibility Testing, 20th Informational Supplement, document M100-S20 (ISBN 1-56238-716-2). Wayne, PA: Clinical and Laboratory Standards Institute.
9. Cooper, K. L., Luey, C. K., Bird, M., Terajima, J., Nair, G. B., Kam, K. M., Arakawa, E., Safa, A., Cheung, D. T. (2006). Development and validation of a PulseNet standardized pulsed-field gel electrophoresis protocol for subtyping of Vibrio cholerae. Foodborne Pathog Dis 3, 51-58.
10. Dalsgaard, A., Forslund, A., Tam, N. V., Vinh, D. X. & Cam, P. D. (1999). Cholera in Vietnam: changes in genotypes and emergence of class I integrons containing aminoglycoside resistance gene cassettes in Vibrio cholerae O1 strains isolated from 1979 to 1996. J Clin Microbiol 37, 734-741.
11. de Saussure, P. P. (2009). Management of the returning traveler with diarrhea. Therap Adv Gastroenterol 2, 367-375.
12. Fluit, A. C., Florijn, A., Verhoef, J. & Milatovic, D. (2005). Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocycline. Antimicrob Agents Chemother 49, 1636-1638.
13. Goel, A. K. & Jiang, S. C. (2010). Genetic determinants of virulence, antibiogram and altered biotype among the Vibrio cholerae O1 isolates from different cholera outbreaks in India. Infect Genet Evol 10, 814-818.
14. Goel, A. K., Jain, M., Kumar, P. & Jiang, S. C. (2010). Molecular characterization of Vibrio cholerae outbreak strains with altered El Tor biotype from southern India. World J Microbiol Biotechnol 26, 281-287.
15. Griffith, D. C., Kelly-Hope, L. A. & Miller, M. A. (2006). Review of reported cholera outbreaks worldwide, 1995-2005. Am J Trop Med Hyg 75, 973-977.
16. Hoshino, K., Yamasaki, S., Mukhopadhyay, A. K., Chakraborty, S., Basu, A., Bhattacharya, S. K., Nair, G. B., Shimada, T. & Takeda, Y. (1998). Development and evaluation of a multiplex PCR assay for rapid detection of toxigenic Vibrio cholerae O1 and O139. FEMS Immunol Med Microbiol 20, 201-207.
17. Ibarra, J. O. & Alvarado, D. E. (2007). Antimicrobial resistance of clinical and environmental strains of Vibrio cholerae isolated in Lima-Peru during epidemics of 1991 and 1998. Braz J Infect Dis 11, 100-105.
18. Islam, M. S., Midzi, S. M., Charimari, L., Cravioto, A. & Endtz, H. P. (2009). Susceptibility to fluoroquinolones of Vibrio cholerae O1 isolated from diarrheal patients in Zimbabwe. JAMA 302, 2321-2322.
19. Jain, M., Goel, A. K., Bhattacharya, P., Ghatole, M. & Kamboj, D. V. (2011). Multidrug resistant Vibrio cholerae O1 El Tor carrying classical ctxB allele involved in a cholera outbreak in South Western India. Acta Trop 117, 152-156.
20. Kaper, J. B., Morris, J. G., Jr & Levine, M. M. (1995). Cholera. Clin Microbiol Rev 8, 48-86.
21. Keasler, S. P. & Hall, R. H. (1993). Detecting and biotyping Vibrio cholerae O1 with multiplex polymerase chain reaction. Lancet 341, 1661.
22. Krishna, B. V., Patil, A. B. & Chandrasekhar, M. R. (2006). Fluoroquinolone-resistant Vibrio cholerae isolated during a cholera outbreak in India. Trans R Soc Trop Med Hyg 100, 224-226.
23. Kumar, P., Wilson, P. A., Bhai, R. & Thomas, S. (2010). Characterization of an SXT variant Vibrio cholerae O1 Ogawa isolated from a patient in Trivandrum, India. FEMS Microbiol Lett 303, 132-136.
24. Mandomando, I., Espasa, M., Vallés, X., Sacarlal, J., Sigaúque, B., Ruiz, J. & Alonso, P. (2007). Antimicrobial resistance of Vibrio cholerae O1 serotype Ogawa isolated in Manhic ̧a District Hospital, southern Mozambique. J Antimicrob Chemother 60, 662-664.
25. Morita, M., Ohnishi, M., Arakawa, E., Bhuiyan, N. A., Nusrin, S., Alam, M., Siddique, A. K., Qadri, F., Izumiya, H. (2008). Development and validation of a mismatch amplification mutation PCR assay to monitor the dissemination of an emerging variant of Vibrio cholerae O1 biotype El Tor. Microbiol Immunol 52, 314-317.
26. Nair, G. B., Faruque, S. M., Bhuiyan, N. A., Kamruzzaman, M., Siddique, A. K. & Sack, D. A. (2002). New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh. J Clin Microbiol 40, 3296-3299.
27. Nair, G. B., Qadri, F., Holmgren, J., Svennerholm, A. M., Safa, A., Bhuiyan, N. A., Ahmad, Q. S., Faruque, S. M., Faruque, A. S. (2006). Cholera due to altered El Tor strains of Vibrio cholerae O1 in Bangladesh. J Clin Microbiol 44, 4211-4213.
28. Nandi, B., Nandy, R. K., Mukhopadhyay, S., Nair, G. B., Shimada, T. & Ghose, A. C. (2000). Rapid method for species-specific identification of Vibrio cholerae using primers targeted to the gene of outer membrane protein OmpW. J Clin Microbiol 38, 4145-4151.
29. Nguyen, T. V., Le, P. V., Le, C. H. & Weintraub, A. (2005). Antibiotic resistance in diarrheagenic Escherichia coli and Shigella strains isolated from children in Hanoi, Vietnam. Antimicrob Agents Chemother 49, 816-819.
30. Nguyen, B. M., Lee, J. H., Cuong, N. T., Choi, S. Y., Hien, N. T., Anh, D. D., Lee, H. R., Ansaruzzaman, M., Endtz, H. P. (2009). Cholera outbreaks caused by an altered Vibrio cholerae O1 El Tor biotype strain producing classical cholera toxin B in Vietnam in 2007 to 2008. J Clin Microbiol 47, 1568-1571.
31. Nusrin, S., Gil, A. I., Bhuiyan, N. A., Safa, A., Asakura, M., Lanata, C. F., Hall, E., Miranda, H., Huapaya, B. (2009). Peruvian Vibrio cholerae O1 El Tor strains possess a distinct region in the Vibrio seventh pandemic island-II that differentiates them from the prototype seventh pandemic El Tor strains. J Med Microbiol 58, 342-354.
32. Okada, K., Chantaroj, S., Roobthaisong, A., Hamada, S. & Sawanpanyalert, P. (2010). A cholera outbreak of the Vibrio cholerae O1 El Tor variant carrying classical CtxB in northeastern Thailand in 2007. Am J Trop Med Hyg 82, 875-878.
33. Quilici, M. L., Massenet, D., Gake, B., Bwalki, B. & Olson, D. M. (2010). Vibrio cholerae O1 variant with reduced susceptibility to ciprofloxacin, Western Africa. Emerg Infect Dis 16, 1804-1805.
34. Raychoudhuri, A., Mukhopadhyay, A. K., Ramamurthy, T., Nandy, R. K., Takeda, Y. & Nair, G. B. (2008). Biotyping of Vibrio cholerae O1: time to redefine the scheme. Indian J Med Res 128, 695-698.
35. Sack, D. A., Sack, R. B., Nair, G. B. & Siddique, A. K. (2004). Cholera. Lancet 363, 223-233.
36. Safa, A., Nair, G. B. & Kong, R. Y. (2010). Evolution of new variants of Vibrio cholerae O1. Trends Microbiol 18, 46-54.
37. Saha, D., Karim, M. M., Khan, W. A., Ahmed, S., Salam, M. A. & Bennish, M. L. (2006). Single-dose azithromycin for the treatment of cholera in adults. N Engl J Med 354, 2452-2462.
38. WHO (2005). The Treatment of Diarrhoea: a Manual for Physicians and Other Senior Health Workers, 4th rev. Geneva: World Health Organization.
39. Zuckerman, J. N., Rombo, L. & Fisch, A. (2007). The true burden and risk of cholera: implications for prevention and control. Lancet Infect Dis 7, 521-530.